Stratasys(SSYS) - 2023 Q2 - Earnings Call Transcript

Financial Data and Key Metrics Changes - Consolidated revenue for Q2 2023 was $159.8 million, up 2% adjusted for constant currency, but down 4.1% compared to Q2 2022 [25] - GAAP gross margin improved to 41.5% from 40.5% year-over-year, while non-GAAP gross margin increased to 48.5% from 47.6% [28] - GAAP net loss for the quarter was $38.6 million or $0.56 per diluted share, compared to a net loss of $24.4 million or $0.37 per diluted share in the same period last year [30] Business Line Data and Key Metrics Changes - Product revenue declined by 5.7% to $109.1 million, with system revenue down 17.9% to $48.3 million, but consumables revenue rose by 6.9% to $60.8 million, marking a record level [26][27] - Service revenue was essentially flat at $50.7 million, but customer service revenue reached its highest ever, reflecting increased utilization rates [27] Market Data and Key Metrics Changes - Strength was noted in automotive, aerospace, and government sectors for production of end-use parts, with significant sales to customers like BMW and the U.S. Air Force [27][18] - The dental market is highlighted as a $5 billion addressable market, with only 5% currently coming from additive manufacturing, indicating substantial growth potential [16] Company Strategy and Development Direction - The company aims to achieve over $1 billion in organic revenue by 2026, focusing on substantial improvements in profitability and growth through strategic acquisitions like Desktop Metal [11][12] - The acquisition of Covestro's additive manufacturing materials business is expected to enhance the company's offerings and contribute to growth in consumables [23] Management's Comments on Operating Environment and Future Outlook - Management acknowledged ongoing macroeconomic challenges but expressed confidence in customer demand and engagement, particularly in the U.S. market [12][42] - The company reiterated its revenue guidance for 2023 of $630 million to $670 million, expecting sequential growth in the latter half of the year [32] Other Important Information - The company ended the quarter with over $200 million in cash and equivalents and no debt, supporting future growth and acquisition opportunities [14] - The FDA clearance of Axial3D's automated cloud-based medical segmentation software is expected to accelerate the adoption of 3D printed medical models [20] Q&A Session Summary Question: Visibility levels and outlook compared to peers - Management noted that while the industry is facing challenges, Stratasys's diversified offerings and growth engines provide good visibility for the second half of the year [41][42] Question: Guidance for next year and growth drivers - Management highlighted the impact of acquisitions like Covestro and ongoing growth in consumables and software as key drivers for expected growth in 2024 [44][46] Question: Order delays and sales cycle - Management confirmed longer sales cycles but did not see significant order push-outs, attributing better engagement in the U.S. market [49] Question: Integration with Desktop Metal - Management remains confident in the complementary nature of the two businesses, expecting significant synergies from the merger [50] Question: Contribution of Covestro to growth - Covestro contributed $4.6 million in revenue for the quarter, with expectations for further growth in 2024 [53][54] Question: Dental market opportunities - Management emphasized the unique position in the dental market, particularly with the J3 Dentajet and DLP technologies, which are expected to drive significant growth [60][62] Question: SAF technology and revenue growth - Management reported improvements in SAF technology and is optimistic about its future contributions to revenue growth [64]